{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T04:36:56Z","timestamp":1794199016512,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T00:00:00Z","timestamp":1305244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2369-12-20","type":"journal-article","created":{"date-parts":[[2011,5,13]],"date-time":"2011-05-13T06:19:19Z","timestamp":1305267559000},"source":"Crossref","is-referenced-by-count":43,"title":["Do aluminium-based phosphate binders continue to have a role in contemporary nephrology practice?"],"prefix":"10.1186","volume":"12","author":[{"given":"David W","family":"Mudge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmel M","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M","family":"Isbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn L","family":"van Eps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James JB","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,13]]},"reference":[{"key":"204_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1172\/JCI106517","volume":"50","author":"E Slatopolsky","year":"1971","unstructured":"Slatopolsky E, Caglar S, Pennell JP, Taggart DD, Canterbury JM, Reiss E, et al: On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J Clin Invest. 1971, 50: 492-499. 10.1172\/JCI106517.","journal-title":"J Clin Invest"},{"key":"204_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/00002480-197301900-00077","volume":"19","author":"E Rutherford","year":"1973","unstructured":"Rutherford E, Mercado A, Hruska K, Harter H, Mason N, Sparks R, et al: An evaluation of a new and effective phosphorus binding agent. Trans Am Soc Artif Intern Organs. 1973, 19: 446-449.","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"204_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1056\/NEJM197601222940402","volume":"294","author":"AC Alfrey","year":"1976","unstructured":"Alfrey AC, LeGendre GR, Kaehny WD: The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med. 1976, 294: 184-188. 10.1056\/NEJM197601222940402.","journal-title":"N Engl J Med"},{"key":"204_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/0022-510X(92)90291-R","volume":"107","author":"JM Candy","year":"1992","unstructured":"Candy JM, McArthur FK, Oakley AE, Taylor GA, Chen CP, Mountfort SA, et al: Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure. J Neurol Sci. 1992, 107: 210-218. 10.1016\/0022-510X(92)90291-R.","journal-title":"J Neurol Sci"},{"key":"204_CR5","first-page":"168","volume":"28","author":"MD Arenas","year":"2008","unstructured":"Arenas MD, Malek T, Gil MT, Moledous A, Nunez C, Alvarez-Ude F: [Use of the aluminum phosphate-binders in hemodialysis in the ultrapure water era]. Nefrologia. 2008, 28: 168-173.","journal-title":"Nefrologia"},{"key":"204_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/ki.1981.56","volume":"19","author":"H Graf","year":"1981","unstructured":"Graf H, Stummvoll HK, Meisinger V, Kovarik J, Wolf A, Pinggera WF: Aluminum removal by hemodialysis. Kidney Int. 1981, 19: 587-592. 10.1038\/ki.1981.56.","journal-title":"Kidney Int"},{"key":"204_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0140-6736(79)90883-3","volume":"1","author":"IS Parkinson","year":"1979","unstructured":"Parkinson IS, Ward MK, Feest TG, Fawcett RW, Kerr DN: Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet. 1979, 1: 406-409.","journal-title":"Lancet"},{"key":"204_CR8","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/S0140-6736(76)92177-2","volume":"1","author":"JA Flendrig","year":"1976","unstructured":"Flendrig JA, Kruis H, Das HA: Letter: Aluminum and dialysis dementia. Lancet. 1976, 1: 1235-","journal-title":"Lancet"},{"key":"204_CR9","first-page":"226","volume":"17","author":"AI Short","year":"1980","unstructured":"Short AI, Winney RJ, Robson JS: Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication. Proc Eur Dial Transplant Assoc. 1980, 17: 226-233.","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"204_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/ki.1987.177","volume":"32","author":"GD Smith","year":"1987","unstructured":"Smith GD, Winney RJ, McLean A, Robson JS: Aluminium-related osteomalacia: response to reverse osmosis water treatment. Kidney Int. 1987, 32: 96-101. 10.1038\/ki.1987.177.","journal-title":"Kidney Int"},{"key":"204_CR11","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1093\/ndt\/12.12.2679","volume":"12","author":"S Mazzaferro","year":"1997","unstructured":"Mazzaferro S, Perruzza I, Costantini S, Pasquali M, Onorato L, Sardella D, et al: Relative roles of intestinal absorption and dialysis-fluid-related exposure in the accumulation of aluminium in haemodialysis patients. Nephrol Dial Transplant. 1997, 12: 2679-2682. 10.1093\/ndt\/12.12.2679.","journal-title":"Nephrol Dial Transplant"},{"key":"204_CR12","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1001\/archneur.1981.00510100084016","volume":"38","author":"CM Foley","year":"1981","unstructured":"Foley CM, Polinsky MS, Gruskin AB, Baluarte HJ, Grover WD: Encephalopathy in infants and children with chronic renal disease. Arch Neurol. 1981, 38: 656-658.","journal-title":"Arch Neurol"},{"key":"204_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1440-1754.1992.tb02658.x","volume":"28","author":"L Woodard-Knight","year":"1992","unstructured":"Woodard-Knight L, Fudge A, Teubner J, Simmer K: Aluminium absorption and antacid therapy in infancy. J Paediatr Child Health. 1992, 28: 257-259. 10.1111\/j.1440-1754.1992.tb02658.x.","journal-title":"J Paediatr Child Health"},{"key":"204_CR14","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJM198404263101704","volume":"310","author":"SP Andreoli","year":"1984","unstructured":"Andreoli SP, Bergstein JM, Sherrard DJ: Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med. 1984, 310: 1079-1084. 10.1056\/NEJM198404263101704.","journal-title":"N Engl J Med"},{"key":"204_CR15","first-page":"171","volume":"32","author":"AA Bakir","year":"1986","unstructured":"Bakir AA, Hryhorczuk DO, Berman E, Dunea G: Acute fatal hyperaluminemic encephalopathy in undialyzed and recently dialyzed uremic patients. ASAIO Trans. 1986, 32: 171-176.","journal-title":"ASAIO Trans"},{"key":"204_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00000441-198901000-00003","volume":"297","author":"BB Kirschbaum","year":"1989","unstructured":"Kirschbaum BB, Schoolwerth AC: Acute aluminum toxicity associated with oral citrate and aluminum-containing antacids. Am J Med Sci. 1989, 297: 9-11. 10.1097\/00000441-198901000-00003.","journal-title":"Am J Med Sci"},{"key":"204_CR17","first-page":"237","volume":"114","author":"DH Froment","year":"1989","unstructured":"Froment DH, Buddington B, Miller NL, Alfrey AC: Effect of solubility on the gastrointestinal absorption of aluminum from various aluminum compounds in the rat. J Lab Clin Med. 1989, 114: 237-242.","journal-title":"J Lab Clin Med"},{"key":"204_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ki.1989.286","volume":"36","author":"BA Molitoris","year":"1989","unstructured":"Molitoris BA, Froment DH, Mackenzie TA, Huffer WH, Alfrey AC: Citrate: a major factor in the toxicity of orally administered aluminum compounds. Kidney Int. 1989, 36: 949-953. 10.1038\/ki.1989.286.","journal-title":"Kidney Int"},{"key":"204_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1053\/j.ajkd.2005.04.020","volume":"46","author":"JA Jaffe","year":"2005","unstructured":"Jaffe JA, Liftman C, Glickman JD: Frequency of elevated serum aluminum levels in adult dialysis patients. Am J Kidney Dis. 2005, 46: 316-319. 10.1053\/j.ajkd.2005.04.020.","journal-title":"Am J Kidney Dis"},{"key":"204_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1258\/0004563053026862","volume":"42","author":"PM Gault","year":"2005","unstructured":"Gault PM, Allen KR, Newton KE: Plasma aluminium: a redundant test for patients on dialysis?. Ann Clin Biochem. 2005, 42: 51-54. 10.1258\/0004563053026862.","journal-title":"Ann Clin Biochem"},{"key":"204_CR21","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0272-6386(99)70394-X","volume":"34","author":"AT Kausz","year":"1999","unstructured":"Kausz AT, Antonsen JE, Hercz G, Pei Y, Weiss NS, Emerson S, et al: Screening plasma aluminum levels in relation to aluminum bone disease among asymptomatic dialysis patients. Am J Kidney Dis. 1999, 34: 688-693. 10.1016\/S0272-6386(99)70394-X.","journal-title":"Am J Kidney Dis"},{"key":"204_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1440-1797.2006.00712.x","volume":"12","author":"CL van Eps","year":"2007","unstructured":"van Eps CL, Jeffries JK, Anderson JA, Bergin PT, Johnson DW, Campbell SB, et al: Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis. Nephrology (Carlton). 2007, 12: 224-233. 10.1111\/j.1440-1797.2006.00712.x.","journal-title":"Nephrology (Carlton)"},{"key":"204_CR23","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004, 15: 2208-2218. 10.1097\/01.ASN.0000133041.27682.A2.","journal-title":"J Am Soc Nephrol"},{"key":"204_CR24","doi-asserted-by":"crossref","unstructured":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003, 42: S1-201.","DOI":"10.1016\/S0272-6386(03)00905-3"},{"key":"204_CR25","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2215\/CJN.04211007","volume":"3","author":"SC Cheng","year":"2008","unstructured":"Cheng SC, Young DO, Huang Y, Delmez JA, Coyne DW: A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients. Clin J Am Soc Nephrol. 2008, 3: 1131-1138. 10.2215\/CJN.04211007.","journal-title":"Clin J Am Soc Nephrol"},{"key":"204_CR26","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1523-1755.2004.00877.x","volume":"66","author":"B Manns","year":"2004","unstructured":"Manns B, Stevens L, Miskulin D, Owen WF, Winkelmayer WC, Tonelli M: A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the USA. Kidney Int. 2004, 66: 1239-1247. 10.1111\/j.1523-1755.2004.00877.x.","journal-title":"Kidney Int"},{"key":"204_CR27","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","volume":"72","author":"WN Suki","year":"2007","unstructured":"Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, et al: Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int. 2007, 72: 1130-1137. 10.1038\/sj.ki.5002466.","journal-title":"Kidney Int"},{"key":"204_CR28","first-page":"111","volume":"45","author":"MJ Janssen","year":"1996","unstructured":"Janssen MJ, van der KA, ter Wee PM, van Boven WP: Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients. Clin Nephrol. 1996, 45: 111-119.","journal-title":"Clin Nephrol"},{"key":"204_CR29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/089686080602600308","volume":"26","author":"KP Katopodis","year":"2006","unstructured":"Katopodis KP, Andrikos EK, Gouva CD, Bairaktari ET, Nikolopoulos PM, Takouli LK, et al: Sevelamer hydrochloride versus aluminum hydroxide: effect on serum phosphorus and lipids in CAPD patients. Perit Dial Int. 2006, 26: 320-327.","journal-title":"Perit Dial Int"},{"key":"204_CR30","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1093\/ndt\/gfl146","volume":"21","author":"GB Spasovski","year":"2006","unstructured":"Spasovski GB, Sikole A, Gelev S, Masin-Spasovska J, Freemont T, Webster I, et al: Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up. Nephrol Dial Transplant. 2006, 21: 2217-2224. 10.1093\/ndt\/gfl146.","journal-title":"Nephrol Dial Transplant"},{"key":"204_CR31","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1523-1755.2005.00171.x","volume":"67","author":"B Lacour","year":"2005","unstructured":"Lacour B, Lucas A, Auchere D, Ruellan N, Serre Patey NM, Drueke TB: Chronic renal failure is associated with increased tissue deposition of lanthanum after 28-day oral administration. Kidney Int. 2005, 67: 1062-1069. 10.1111\/j.1523-1755.2005.00171.x.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-12-20\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-12-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-12-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-12-20.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T03:44:58Z","timestamp":1592538298000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-12-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,13]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["204"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-12-20","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,13]]},"article-number":"20"}}